H.Res. 1434 · 117th Congress

Reaffirming the preemptive authority of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) and the Public Health Service Act (42 U.S.C. 201 et seq.) (including regulations thereunder) with respect to State laws that inhibit access to or use of any reproductive health product.

Stage
Passed chamber resolution
Sponsor
Mondaire Jones
Introduced
2022-10-14
Latest action
2022-12-22 · Pursuant to the provisions of H. Res. 1529, H. Res. 1434 is considered passed House.

Action history

  1. 2022-12-22Pursuant to the provisions of H. Res. 1529, H. Res. 1434 is considered passed House.
  2. 2022-10-17Referred to the Subcommittee on Health.
  3. 2022-10-14Introduced in House
  4. 2022-10-14Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  5. 2022-10-14Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.